Skip to main content

Articles

Page 9 of 16

  1. Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO us...

    Authors: Wayne Jones, Lenka Vojtila, Paul Kurdyak and Benedikt Fischer
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:68
  2. The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries acr...

    Authors: Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:72
  3. Medical products are an integral and pivotal part of health care delivery. They need to be available, affordable and quality-assured. The SADC region is prone to threats arising from the availability and use o...

    Authors: Stanislav Kniazkov, Sakhile Dube-Mwedzi and Jean-Baptiste Nikiema
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:71
  4. Little is known about how much public payers spend on orphan medicines. This study aimed at identifying information on orphan medicine expenditure incurred by public payers that was published in literature glo...

    Authors: Margit Gombocz and Sabine Vogler
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:66
  5. A dispensing error can be defined as an inconsistency between the drug prescribed and drug dispensed to a patient. These errors can lead to ineffective and sometimes unwanted pharmaceutical outcomes. Dispensin...

    Authors: Sandeep Maharaj, Adrian Brahim, Horry Brown, Danielle Budraj, Vatalie Caesar, Anyse Calder, Deisha Carr, Dion Castillo, Kevin Cedeno and Manthan D. Janodia
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:67
  6. Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for...

    Authors: Colin Whaley, Ashley Bancsi, Joanne Man-Wai Ho, Catherine M. Burns and Kelly Grindrod
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:63
  7. Antibiotic resistance (ABX-R) is alarming in lower/middle-income countries (LMICs). Nonadherence to antibiotic guidelines and inappropriate prescribing are significant contributing factors to ABX-R. This study...

    Authors: Kashif Hussain, Muhammad Faisal Khan, Gul Ambreen, Syed Shamim Raza, Seema Irfan, Kiren Habib and Hasnain Zafar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:69
  8. Access to quality-assured, safe and efficacious medical products is fundamental for Universal Health Coverage and attaining Sustainable Development Goal 3: Ensure Healthy Lives and Well-being for All. To guara...

    Authors: S. Dube-Mwedzi, S. Kniazkov, J. B. Nikiema, O. M. J. Kasilo, A. Fortin, P. Tumusiime, G. N. Mahlangu and M. Ndomondo-Sigonda
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:64
  9. Due to a liberalisation reform in 2009, the availability of over-the-counter (OTC) analgesics has increased significantly in the Swedish market over the past decade. With the increasing number of generic produ...

    Authors: Helle Håkonsen, Maria Wängberg, Dina Alani and Tove Hedenrud
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:60
  10. In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since 2015, Swiss pharmacists are allowed to vaccinate healthy adults after acqu...

    Authors: Dominik Stämpfli, Adrian Martinez-De la Torre, Sophie Du Pasquier, Danielle Stegmann, Andrea Brügger and Andrea M. Burden
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:57
  11. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The nature of healthcare providers’ occupation puts them at an increased risk of getting any contagious disease...

    Authors: Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:53
  12. With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antivira...

    Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski and Aleksandra Grozdanova
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:61
  13. During the COVID-19 pandemic, the Lebanese government has taken the proactive anticipatory measure to minimize the infection rates. Despite the pivotal role of the pharmacists working in hospital settings, hos...

    Authors: Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:54
  14. The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is how to ensure the efficient and effective procurement of q...

    Authors: Jillian Clare Kohler and Tom Wright
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:58
  15. Regulatory inspection of private drug shops in Uganda is a mandate of the Ministry of Health carried out by the National Drug Authority. This study evaluated how this mandate is being carried out at national, ...

    Authors: Arthur Bagonza, Stefan Peterson, Andreas Mårtensson, Henry Wamani, Phyllis Awor, Milton Mutto, David Musoke, Linda Gibson and Freddy Eric Kitutu
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:55
  16. The Caribbean Regulatory System is a centralized medicine assessment procedure established to serve the needs of the Member States of the CARICOM region. In order to better understand the effectiveness and eff...

    Authors: Lawrence Liberti, Rian Marie Extavour, Prisha Patel and Neil McAuslane
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:56
  17. Maintaining an efficient and effective inventory management system ensures a reliable supply of laboratory commodities. The aim of this study was, therefore, to assess the performance of inventory management f...

    Authors: Abdi Befekadu, Waqtola Cheneke, Dereje Kebebe and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:49
  18. To strengthen appropriate medicine use (AMU) including the prescribing and dispensing quality at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged approach known as th...

    Authors: Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:48
  19. Iranian government has introduced multiple healthcare system reforms during the last 30 years aiming at improving accessibility and affordability of care. Pharmaceutical products are one of the major sources o...

    Authors: Saman Zartab, Nasrin Nassiri Koopaei, Hadi Abbasian, Mansur Nassiri Koopaei and Nasser Nassiri Koopaei
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:50
  20. Most pharmacists agree that continuing education (CE) programs positively affect their practice and increase their knowledge, with computer-based courses being their preferred type of CE (60.6%). The route to ...

    Authors: Souheil Hallit, Samah Tawil, Hala Sacre, Clara Rahme, Aline Hajj and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:44
  21. This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and...

    Authors: F. Alves da Costa, M. Henman, C. Hughes, H. Leufkens, Z. Babar, J. McElnay and M. Schulz
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:51
  22. Amiodarone is known for its efficacy as an antiarrhythmic agent; however, its extensive side-effect profile requires careful selection of patients and frequent monitoring. The purpose of this study was to eval...

    Authors: Bander Ahmed Albassam, Nouf Mohammed Almutairi, Sarah Fahad Aldosari and Hind Saleh Almodaimegh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:37
  23. In March 2020, the World Health Organization (WHO) declared the coronavirus infectious disease as a pandemic referred to as COVID-19. As an essential service, community pharmacists have been enacting a key rol...

    Authors: Iman A. Basheti, Razan Nassar, Muna Barakat, Rajaa Alqudah, Rana Abu Farha, Tareq Muqatash, Samar Thiab and Bandana Saini
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:62
  24. Empathy is the cornerstone of the relationship between the healthcare provider and the patient. In Lebanon, no studies have investigated the factors associated with empathy among community pharmacists. Hence, ...

    Authors: Eva Hobeika, Souheil Hallit, Hala Sacre, Sahar Obeid, Aline Hajj and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:32
  25. Universal access to high quality essential medicines is critical to sustainable development (SDG 3.8). However low- and middle-income countries struggle to ensure access to all medicines on their national esse...

    Authors: Petra Brhlikova, Karen Maigetter, Jude Murison, Amon G. Agaba, Jonans Tusiimire and Allyson M. Pollock
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:31
  26. Resistant strains of bacteria are rapidly emerging with increasing inappropriate use of antibiotics rendering them less efficacious. Self-purchasing of antibiotics particularly for viral infections is a key dr...

    Authors: Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, Munazzah Fatima, Zeenia Ahmad, Areeba Sajid, Inaam Ur Rehman, Muhammad Umer Nadeem, Zaida Javaid, Madeeha Malik and Azhar Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:26
  27. Since SARS-CoV2 was declared a Public Health Emergency of International Concern, those tasked with the stewardship of public health at a global, regional, and local level—policymakers, politicians, scientists, dr...

    Authors: Jerome Amir Singh and Rafaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:47
  28. There is limited published data form Pakistan on treatment success rate among extrapulmonary tuberculosis (EPTB) patients. The aim of this study was to assess clinical form, treatment outcomes, and identify th...

    Authors: Muhammad Atif, Razia Fatima, Nafees Ahmad and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:35
  29. The coronavirus disease 2019 (COVID-19) impact on the mental health of healthcare workers is extremely detrimental. It is imperative that the psychological health of all healthcare workers be protected. Howeve...

    Authors: Ali Elbeddini, Cindy Xin Wen, Yasamin Tayefehchamani and Anthony To
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:46
  30. Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica...

    Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45
  31. Potentially inappropriate prescribing (PIP) is associated with the incidence of adverse drug reactions, drug-related hospitalization and other negative outcomes in older adults. After hospitalization, older ad...

    Authors: Muhammad Eid Akkawi, Mohamad Haniki Nik Mohamed and Mohd Aznan Md Aris
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:39
  32. High prices of pharmaceutical products are an increasing challenge in high- and low-income countries. Governments in many countries have implemented pricing policies to ensure affordability of medicines to pat...

    Authors: David Tordrup, Hendrika A. van den Ham, Julie Glanville and Aukje K. Mantel-Teeuwisse
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:22
  33. The novel coronavirus disease 2019 (COVID-19) pandemic is a global challenge. Improving public awareness about preventive measures and disseminating appropriate information about COVID-19 has a critical role i...

    Authors: Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat and Ammar Abdulrahman Jairoun
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:43
  34. Coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global pandemic. COVID-19 is spreading in Africa, and Zimbabwe has not been spared. The cases in Zimbabwe are mainly from imported...

    Authors: B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya and D. Tagwireyi
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:42
  35. The latest outbreak of Covid-19 pandemic has placed a significant effect on health care system around the world. This article discusses the role of pharmacists in Saudi Arabia during the current Covid-19 pande...

    Authors: Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah and Abdulaziz Alhossan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:41
  36. Pharmacies in Europe have undergone considerable changes in their regulation over the last decades, also regarding nonprescription medicines (NPMs). In 2001, selected NPMs were released for sale outside pharma...

    Authors: Solveig Nordahl Jacobsen, Simone Eggert Møller-Jensen and Sofia Kälvemark Sporrong
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:29
  37. The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining ch...

    Authors: Tamara Hafner, Marlon Banda, Jillian Kohler, Zaheer-Ud-Din Babar, Murray Lumpkin, Mojisola Christianah Adeyeye, Emmanuel Nfor, Francis Aboagye-Nyame and Javier Guzman
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:38
  38. Experiential education is a core element in developing the ability of pharmacy students to apply theory to practice, solve problems, and acquire standard pharmacist competencies. To achieve this goal, precepto...

    Authors: Abeer Zeitoun, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:21
  39. In the fight against COVID-19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions’ efforts have been inconsistent at all levels. Pharmacists arou...

    Authors: Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi and Cindy Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:36
  40. In Malaysia, for more than a decade, dipeptidyl peptidase-4 inhibitors (DPP-4i) are among the oral antidiabetic medications used as monotherapy or in combination to manage type II diabetes mellitus (T2DM). The...

    Authors: Woh Yon Mak, Jivanraj R. Nagarajah, Hannah Abdul Halim, Anitha Ramadas, Zulsairi Mohd Pauzi, Lay Ting Pee and Nirmala Jagan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:34
  41. SARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provi...

    Authors: Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge and Sotiris Antoniou
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:12
  42. Data regarding prolonged length of hospital stay (PLOS) and in-hospital mortality are paramount to evaluate efficiency and quality of surgical care as well as for rational resource utilization, allocation, and...

    Authors: Gosaye Mekonen Tefera, Beshadu Bedada Feyisa, Gurmu Tesfaye Umeta and Tsegaye Melaku Kebede
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:24
  43. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:30

    The original article was published in Journal of Pharmaceutical Policy and Practice 2020 13:18

  44. In 2015, the drive-through pharmacy was first introduced in Queen Elizabeth Hospital (QEH), Malaysia as one of the pharmacy value-added services. Therefore, it is imperative to review the service for further a...

    Authors: Jerry Ee Siung Liew, Aizan Adifarhan bin Abdul Gapar and Lik Ting Shim
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:27
  45. Access to safe, effective, quality and affordable essential medicines for all is a central component of Universal Health Coverage (UHC). However, the availability of quality medicines in peripheral healthcare ...

    Authors: August Kuwawenaruwa, Fabrizio Tediosi, Brigit Obrist, Emmy Metta, Fiona Chiluda, Karin Wiedenmayer and Kaspar Wyss
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:25
  46. Antibiotic resistance poses a great threat to global health, especially in low- and middle-income countries with a high infectious disease burden and limited resources. In spite of regulations, antibiotics are...

    Authors: Mohammad Abdul Matin, Wasif Ali Khan, Mohammad Mahbubul Karim, Sabeena Ahmed, Johannes John-Langba, Osman A. Sankoh, Margaret Gyapong, John Kinsman and Heiman Wertheim
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:20

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2023 Usage
    852,978 downloads
    963 Altmetric mentions